Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Lidds AB | 87,125 | net | 10 Feb 2023 | tx 8+87,125 |
| NeuroVive Pharmaceutical AB | -45,828 | net | 07 Feb 2025 | tx 9+2,723,177−2,769,005 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 07 Feb 2025 | SALE | NeuroVive Pharmaceutical AB | 1,500,000 | 0.04 SEK | deriv |
| 07 Feb 2025 | SALE | NeuroVive Pharmaceutical AB | 1,000,000 | 0.05 SEK | deriv |
| 07 Feb 2025 | SALE | NeuroVive Pharmaceutical AB | 269,005 | 0.45 SEK | |
| 28 May 2024 | GRANT_AWARD | NeuroVive Pharmaceutical AB | 1,000,000 | 0.03 SEK | deriv |
| 17 Apr 2024 | GRANT_AWARD | NeuroVive Pharmaceutical AB | 132,645 | 0.16 SEK | |
| 29 May 2023 | GRANT_AWARD | NeuroVive Pharmaceutical AB | 1,500,000 | 0.05 SEK | deriv |
| 10 Feb 2023 | PURCHASE | Lidds AB | 53,750 | 1.40 SEK | |
| 07 Feb 2023 | OTHER | Lidds AB | 5,625 | 0.00 SEK | deriv |
| 07 Feb 2023 | PURCHASE | Lidds AB | 5,625 | 1.40 SEK | |
| 27 Jun 2022 | PURCHASE | NeuroVive Pharmaceutical AB | 36,360 | 0.35 SEK | first after silence |
| 21 May 2021 | PURCHASE | NeuroVive Pharmaceutical AB | 25,000 | 0.72 SEK | |
| 11 Sept 2020 | PURCHASE | NeuroVive Pharmaceutical AB | 29,172 | 0.99 SEK | |
| 02 Jul 2020 | PURCHASE | Lidds AB | 625 | 12.00 SEK | |
| 26 Sept 2019 | PURCHASE | Lidds AB | 500 | 17.70 SEK | |
| 10 Jun 2019 | PURCHASE | Lidds AB | 16,500 | 1.00 SEK | deriv |
| 10 Jul 2019 | PURCHASE | Lidds AB | 1,000 | 17.05 SEK | |
| 15 Jul 2019 | PURCHASE | Lidds AB | 3,500 | 16.90 SEK |
1 purchase reported after at least 12 months of silence — most recent on 27 Jun 2022.